With vast amounts of data being generated it is important to make the right decision when it comes to appropriate cut-points. In this presentation, Alexandra Hawes (Principal Scientist, LGC, UK), outlines the collaborative process in the context of updated recommendations for statistical analyses. She also discusses the importance of the analytical scientists understanding of how the statistical analysis should be applied and its appropriateness for analytical data. Also included in the presentation are three case studies that illustrate the importance of the collaborative relationship between statisticians and scientists.
Types of anti-drug antibody regulated methods validated in the last 12 months at KCAS Bioanalytical & Biomarker Services
Find out more about the types of Anti-Drug Antibody (ADA) regulated methods validated in the last 12 months at KCAS Bioanalytical & Biomarker Services.
Find out more an electrochemiluminescent bridging immunogenicity assay used to measure anti-drug antibodies in human serum using an acid dissociation step in this poster from KCAS Bioanalytical & Biomarker Services (KS, USA).
As part of our Spotlight on immunogenicity, we carried out a survey to gain an insight into the trends, challenges and developments associated with immunogenicity testing. We would like to thank everyone who was able to share their thoughts by taking part in the survey.
Find out more about working with immunogenicity as well as what the future may hold for the field in this interview with Joyce Slusser (KCAS).
Webinar available to view on demand. Methods for the detection of drug-induced antibodies have become much more sensitive, but the question remains to be answered: are antibodies at this low concentration level clinically relevant?